Understanding Side Effects and Safety of GLP-1 Medications The most common side effects during GLP-1 therapy include mild nausea, constipation, and decreased appetitereactions that typically diminish within 2-4 weeks as your body adjusts
[7][8] Semaglutide is a GLP-1 receptor agonist
Administered as a once-weekly subcutaneous injection, mazdutide shows promise as a long-term treatment option [3] [4] Mazdutide vs Tirzepatide Type 2 Diabetes Both mazdutide and tirzepatide address the growing challenge of type 2 diabetes, a condition affecting millions globally, characterized by insulin resistance and increased blood sugar
increasing dose over time as your body adjusts), side effects generally start off mild and get worse in the short-term as the dose increases
Factors like genetics, starting weight, diet, exercise habits, and other health conditions all influence how well these medications work for each person